Published in Pediatrics on September 01, 1988
Helicobacter pylori. Arch Dis Child (1990) 1.55
Unusual presentations of eosinophilic gastroenteritis: case series and review of literature. World J Gastroenterol (2009) 1.29
Growth in children with Helicobacter pylori infection and dyspepsia. Arch Dis Child (2005) 0.90
Gastric metaplasia and duodenal ulcer disease in children infected by Helicobacter pylori. Gut (1996) 0.89
Impact of H. pylori on growth: is the infection or mucosal disease related to growth impairment? Dig Dis Sci (2010) 0.83
Effect of Helicobacter pylori eradication on the natural history of duodenal ulcer disease. Arch Dis Child (1998) 0.81
How should Helicobacter pylori infected children be managed? Gut (1999) 0.76
Effect of early and current Helicobacter pylori infection on the risk of anaemia in 6.5-year-old Ethiopian children. BMC Infect Dis (2015) 0.75
Advances in the treatment of Helicobacter pylori infection in children. Ann Gastroenterol (2015) 0.75
Intrafamilial clustering of Helicobacter pylori infection. N Engl J Med (1990) 5.09
Helicobacter pylori: new developments and treatments. CMAJ (1997) 2.77
Distinct binding properties of eaeA-negative verocytotoxin-producing Escherichia coli of serotype O113:H21. Infect Immun (1994) 2.37
Corticotropin-releasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro. Gut (2007) 2.03
Reduced serum amino acid concentrations in infants with necrotizing enterocolitis. J Pediatr (2000) 1.97
A further study on measles vaccination in Nigerian children. Bull World Health Organ (1965) 1.85
Infection of T84 cells with enteropathogenic Escherichia coli alters barrier and transport functions. Am J Physiol (1996) 1.84
Signal transduction responses following adhesion of verocytotoxin-producing Escherichia coli. Infect Immun (1995) 1.79
Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview. CMAJ (1994) 1.78
Microvillus inclusion disease: an inherited defect of brush-border assembly and differentiation. N Engl J Med (1989) 1.77
Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol (1997) 1.74
Screening for celiac disease in children with recurrent abdominal pain. J Pediatr Gastroenterol Nutr (2001) 1.70
Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations. J Pediatr (1995) 1.70
Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut (2006) 1.66
Aneuploidy: a report of an ECETOC task force. Mutat Res (1998) 1.65
Growth and clinical course of children with Crohn's disease. Gut (1993) 1.63
Glutamine stimulates prostaglandin-sensitive Na(+)-H+ exchange in experimental porcine cryptosporidiosis. Gastroenterology (1994) 1.57
Signal transduction in human epithelial cells infected with attaching and effacing Escherichia coli in vitro. Gastroenterology (1994) 1.57
IgA deficiency causes false-negative endomysial antibody results in celiac disease. J Pediatr Gastroenterol Nutr (1996) 1.55
Intussusception: barium or air? J Pediatr Surg (1991) 1.52
High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med (1997) 1.51
Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis. Gut (1980) 1.50
Acute pancreatitis in childhood. J Pediatr (1988) 1.49
Shwachman syndrome: phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar. J Pediatr (1999) 1.47
A position paper of the North American Society for Pediatric Gastroenterology and Nutrition. Pediatric gastroenterology Workforce Survey and future supply and demand. J Pediatr Gastroenterol Nutr (1998) 1.45
Bile acid secretion in cystic fibrosis: evidence for a defect unrelated to fat malabsorption. Gut (1986) 1.44
Helicobacter pylori infection in children: recommendations for diagnosis and treatment. J Pediatr Gastroenterol Nutr (2000) 1.43
Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function. Infect Immun (2008) 1.43
Signal transduction pathways involved in enterohemorrhagic Escherichia coli-induced alterations in T84 epithelial permeability. Infect Immun (1998) 1.40
Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha. Gut (2004) 1.38
Escherichia coli Shiga toxins induce apoptosis in epithelial cells that is regulated by the Bcl-2 family. Am J Physiol Gastrointest Liver Physiol (2000) 1.37
Benefit of ketotifen in patients with eosinophilic gastroenteritis. Am J Med (1991) 1.36
Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency. Pediatr Res (1986) 1.34
Inhibition of attachment of Escherichia coli RDEC-1 to intestinal microvillus membranes by rabbit ileal mucus and mucin in vitro. Infect Immun (1988) 1.32
Effects of long-term nutritional rehabilitation on body composition and clinical status in malnourished children and adolescents with cystic fibrosis. J Pediatr (1985) 1.30
Arteriopathy and coarctation of the abdominal aorta in children with mucopolysaccharidosis: imaging findings. AJR Am J Roentgenol (1991) 1.29
Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group. J Pediatr Gastroenterol Nutr (1999) 1.28
Treatment of distal intestinal obstruction syndrome in cystic fibrosis with a balanced intestinal lavage solution. Lancet (1986) 1.28
Pathology of pancreatic and intestinal disorders in cystic fibrosis. J R Soc Med (1998) 1.28
Skeletal phenotype in patients with Shwachman-Diamond syndrome and mutations in SBDS. Clin Genet (2004) 1.27
Indications for treatment of Helicobacter pylori infection: a systematic overview. CMAJ (1994) 1.27
Neutral lipid storage disease with fatty liver and cholestasis. J Pediatr Gastroenterol Nutr (1997) 1.27
Evidence for a primary defect of pancreatic HCO3-secretion in cystic fibrosis. Pediatr Res (1982) 1.26
Helicobacter pylori induces gastric epithelial cell apoptosis in association with increased Fas receptor expression. Infect Immun (1999) 1.26
Uncertainty in the diagnosis of cystic fibrosis: possible role of in vivo nasal potential difference measurements. J Pediatr (1998) 1.26
Shwachman syndrome: exocrine pancreatic dysfunction and variable phenotypic expression. Gastroenterology (1996) 1.25
Phosphatidylethanolamine recognition promotes enteropathogenic E. coli and enterohemorrhagic E. coli host cell attachment. Microb Pathog (1999) 1.25
Tetanus in childhood: report of a therapeutic trial of diazepam. Br Med J (1966) 1.25
Helicobacter mustelae and Helicobacter pylori bind to common lipid receptors in vitro. Infect Immun (1993) 1.25
Tufting enteropathy: a newly recognized clinicopathological entity associated with refractory diarrhea in infants. J Pediatr Gastroenterol Nutr (1994) 1.25
Serological detection of Helicobacter pylori antibodies in children and their parents. J Clin Microbiol (1994) 1.25
Host-range properties of murine xenotropic and ecotropic type-C viruses. J Natl Cancer Inst (1976) 1.23
Functional heterogeneity of intestinal Escherichia coli strains expressing type 1 somatic pili (fimbriae): assessment of bacterial adherence to intestinal membranes and surface hydrophobicity. Infect Immun (1985) 1.22
Shwachman-Diamond syndrome with exocrine pancreatic dysfunction and bone marrow failure maps to the centromeric region of chromosome 7. Am J Hum Genet (2001) 1.21
Colipase and lipase secretion in childhood-onset pancreatic insufficiency. Delineation of patients with steatorrhea secondary to relative colipase deficiency. Gastroenterology (1984) 1.17
Assessing activity of pediatric Crohn's disease: which index to use? Gastroenterology (1999) 1.17
Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee. J Pediatr (1995) 1.16
Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology (1995) 1.16
Dietary intakes of young children with cystic fibrosis: is there a difference? J Pediatr Gastroenterol Nutr (1996) 1.12
Monocyte/macrophage activation by normal bacteria and bacterial products: implications for altered epithelial function in Crohn's disease. Am J Pathol (2001) 1.11
Pilus-mediated interactions of the Escherichia coli strain RDEC-1 with mucosal glycoproteins in the small intestine of rabbits. Gastroenterology (1987) 1.11
Late gastrointestinal bleeding and protein loss after distal small-bowel resection in infancy. J Pediatr Gastroenterol Nutr (1989) 1.11
Translocation of verotoxin-1 across T84 monolayers: mechanism of bacterial toxin penetration of epithelium. Am J Physiol (1997) 1.10
Development of a quality-of-life index for pediatric inflammatory bowel disease: dealing with differences related to age and IBD type. J Pediatr Gastroenterol Nutr (1999) 1.10
Simple renal cysts in children: diagnosis and follow-up with US. Radiology (1991) 1.09
Capsaicin as an inhibitor of the growth of the gastric pathogen Helicobacter pylori. FEMS Microbiol Lett (1997) 1.03
Malnutrition: a cause of elevated sweat chloride concentration. Acta Paediatr Scand (1986) 1.03
Meconium ileus in the absence of cystic fibrosis. Arch Dis Child (1992) 1.03
Lavage treatment of distal intestinal obstruction syndrome in children with cystic fibrosis. Pediatrics (1989) 1.02
Motivation, medical school admissions, and student performance. J Med Educ (1974) 1.02
Overwork. JAMA (1977) 1.02
Prostaglandins I2 and E2 have a synergistic role in rescuing epithelial barrier function in porcine ileum. J Clin Invest (1997) 1.02
Alpha-actinin accumulation in epithelial cells infected with attaching and effacing gastrointestinal pathogens. J Infect Dis (1995) 1.01
The association of cystic fibrosis, gastroesophageal reflux, and reduced pulmonary function. Can Assoc Radiol J (1988) 1.00
When the doctor needs a doctor: special considerations for the physician-patient. Ann Intern Med (1983) 0.99
Pathogenesis of malnutrition in cystic fibrosis, and its treatment. Clin Nutr (2000) 0.98
Bacterial cell surface hydrophobicity properties in the mediation of in vitro adhesion by the rabbit enteric pathogen Escherichia coli strain RDEC-1. J Clin Invest (1989) 0.98
cagE is a virulence factor associated with Helicobacter pylori-induced duodenal ulceration in children. J Infect Dis (2000) 0.97
Genotypic, clinical, and demographic characteristics of children infected with Helicobacter pylori. J Clin Microbiol (2001) 0.97
Recurrent tracheoesophageal fistulas seventeen-year review. J Pediatr Surg (1983) 0.97
Pulsed-field gel electrophoresis indicates genotypic heterogeneity among Campylobacter upsaliensis strains. FEMS Microbiol Lett (1996) 0.97
Divergent signal transduction responses to infection with attaching and effacing Escherichia coli. Infect Immun (1998) 0.96
Factors influencing postoperative recurrence of Crohn's disease in childhood. Gut (1991) 0.96
Abnormal carotid arteries in the velocardiofacial syndrome: a report of three cases. Plast Reconstr Surg (1987) 0.96
Arginine nutrition in development, health and disease. Curr Opin Clin Nutr Metab Care (2000) 0.95
Long term survival of an infant with sirenomelia. Am J Med Genet (1993) 0.94
Heterogeneity in phenotypic and genotypic characteristics among strains of Hafnia alvei. J Clin Microbiol (1996) 0.93
Colipase and maximally activated pancreatic lipase in normal subjects and patients with steatorrhea. J Clin Invest (1982) 0.93
Cerebral defects and nephrogenic diabetes insipidus with the ARC syndrome: additional findings or a new syndrome (ARCC-NDI)? Am J Med Genet (1997) 0.93
Implications of antibiotic resistance in the management of Helicobacter pylori infection: Canadian Helicobacter Study Group. Can J Gastroenterol (2000) 0.93
Malabsorption of medium-chain triglycerides in infants with cystic fibrosis: correction with pancreatic enzyme supplement. J Pediatr (1980) 0.92
Isolated congenital lipase-colipase deficiency. Gastroenterology (1984) 0.92
Treatment of vitamin K deficiency in cystic fibrosis: Effectiveness of a daily fat-soluble vitamin combination. J Pediatr (2001) 0.92
Inhibition of Helicobacter pylori and Helicobacter mustelae binding to lipid receptors by bovine colostrum. J Infect Dis (1998) 0.92
Role of the enteric nervous system in piglet cryptosporidiosis. J Pharmacol Exp Ther (1996) 0.91
Decline of exocrine pancreatic function in cystic fibrosis patients with pancreatic sufficiency. Pediatr Res (1992) 0.91